4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow ibrexafungerp: new trials by email Literature Review of ibrexafungerp trials Research Report on ibrexafungerp
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp Ibrexafungerp - Vulvovaginal Candidiasis, Candida Infection | Phase 1 | Completed | Scynexis, Inc. | 5 | 2023-07-12 | 2025-08-08 |
| ADME Study of [14^C]-Ibrexafungerp in Healthy Male Subjects Ibrexafungerp - Fungal Disease | Phase 1 | Completed | Scynexis, Inc. | 6 | 2022-12-14 | 2023-06-28 |
| Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy Subjects PRA, SCY-078 plus PRA - Pharmacokinetics | Phase 1 | Completed | Scynexis, Inc. | 28 | 2019-11-22 | 2020-09-02 |
| Study to Evaluate the Effect of SCY-078 on the PK of Dabigatran in Healthy Subjects DAB, SCY-078 plus DAB - Pharmacokinetics | Phase 1 | Completed | Scynexis, Inc. | 36 | 2019-09-09 | 2020-09-02 |
Mycoses (2) · Candidiasis (1) · Candidiasis, Oral (1) · Candidiasis, Vulvovaginal (1)
Scynexis, Inc. (4)
Australia (2) · United Kingdom (1) · United States (1)